We recommend aspirin at a dose of between 81 and 325 mg be considered only in HF patients with clear indications for secondary prevention of CV events (Strong Recommendation, High-Quality Evidence).

We recommend anticoagulation not be used routinely for HFpatients who are in sinus rhythm (Strong Recommendation, High-Quality Evidence).

We recommend anticoagulation be considered for patients with demonstrated intracardiac thrombus, previous systemic embolism, or after a large anterior MI (Weak Recommendation, Low-Quality Evidence).